1:29 PM
 | 
Sep 15, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

BridgeBio raises $135M round

On Sept. 13, BridgeBio Pharma (Palo Alto, Calif.) raised $135 million in an undisclosed venture round led by new investor Viking Global Investors and existing investor KKR.

New investors AIG, Aisling Capital, Cormorant Capital and Janus Funds also participated alongside existing investor Perceptive Advisors.

BridgeBio in-licenses rare genetic disease candidates...

Read the full 234 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >